Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228638![]() (US9345793, 19 | US9744252, Example 19) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228637![]() (US9345793, 18 | US9744252, Example 18) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228638![]() (US9345793, 19 | US9744252, Example 19) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228637![]() (US9345793, 18 | US9744252, Example 18) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228634![]() (US9345793, 15 | US9744252, Example 15) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228634![]() (US9345793, 15 | US9744252, Example 15) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228635![]() (US9345793, 16 | US9744252, Example 16) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228635![]() (US9345793, 16 | US9744252, Example 16) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228639![]() (US9345793, 20 | US9744252, Example 20) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228632![]() (US9345793, 13 | US9744252, Example 13) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228639![]() (US9345793, 20 | US9744252, Example 20) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228632![]() (US9345793, 13 | US9744252, Example 13) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228631![]() (US9345793, 12 | US9744252, Example 12) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228631![]() (US9345793, 12 | US9744252, Example 12) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228626![]() (US9345793, 7 | US9744252, Example 7) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228626![]() (US9345793, 7 | US9744252, Example 7) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228630![]() (US9345793, 11 | US9744252, Example 11) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228627![]() (US9345793, 8 | US9744252, Example 8) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228630![]() (US9345793, 11 | US9744252, Example 11) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228627![]() (US9345793, 8 | US9744252, Example 8) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228633![]() (US9345793, 14 | US9744252, Example 14) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228629![]() (US9345793, 10 | US9744252, Example 10) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228633![]() (US9345793, 14 | US9744252, Example 14) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228629![]() (US9345793, 10 | US9744252, Example 10) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228625![]() (US9345793, 6 | US9744252, Example 6) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228624![]() (US9345793, 5 | US9744252, Example 5) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228624![]() (US9345793, 5 | US9744252, Example 5) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228625![]() (US9345793, 6 | US9744252, Example 6) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228622![]() (US9345793, 3 | US9744252, Example 3) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228622![]() (US9345793, 3 | US9744252, Example 3) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228628![]() (US9345793, 9 | US9744252, Example 9) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228628![]() (US9345793, 9 | US9744252, Example 9) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228621![]() (US9345793, 2 | US9744252, Example 2) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228621![]() (US9345793, 2 | US9744252, Example 2) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228636![]() (US9345793, 17 | US9744252, Example 17) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228636![]() (US9345793, 17 | US9744252, Example 17) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228623![]() (US9345793, 4 | US9744252, Example 4) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 84 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228623![]() (US9345793, 4 | US9744252, Example 4) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 84 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM228620![]() (US9345793, 1 | US9744252, Example 1) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 101 | n/a | n/a | n/a | n/a | n/a | 2 |
PIRAMAL IMAGING SA US Patent | Assay Description The GPIIb/IIIa receptor was immobilized 48 hours at least (100 μL per well, 48 to maximum 96 hours) on a 96-well solid plate (Immuno Plate MaxiSor... | US Patent US9345793 (2016) BindingDB Entry DOI: 10.7270/Q22806GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb (Homo sapiens (Human)) | BDBM228620![]() (US9345793, 1 | US9744252, Example 1) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 101 | n/a | n/a | n/a | n/a | n/a | n/a |
PIRAMAL IMAGING SA US Patent | Assay Description Purified human glycoprotein IIb/IIIa (20 mM Tris-HCl, 0.1 M NaCl, 0.1% Triton X-100, 1 mM CaCl2, 0.05% NaN3, 50% Glycerol, pH 7.4) was purchased from... | US Patent US9744252 (2017) BindingDB Entry DOI: 10.7270/Q2F76FN7 | |||||||||||
More data for this Ligand-Target Pair |